Leica Biosystems, division of Leica Microsystems, Inc.

Leica Biosystems is a global leader in anatomic pathology solutions with 150+ years of heritage. The company specializes in comprehensive workflow automation for histopathology, immunohistochemistry (IHC), in situ hybridization (ISH), and digital pathology. Core product lines include tissue processors, microtomes, cryostats, automated slide stainers (HistoCore CHROMAX, BOND series), and high-throughput digital slide scanners (Aperio GT 450, Aperio GT 180 DX). The company also manufactures histology consumables—slides, coverglass, paraffins, blades, cassettes, reagents, stains, and mounting media—alongside IHC/ISH reagents, antibodies, FISH probes, and detection systems. Digital pathology offerings encompass slide scanning, image management software, and AI-integrated quality control. Leica Biosystems serves hospital labs, academic medical centers, pharmaceutical research, and companion diagnostics workflows. The company operates CEREBRO specimen tracking and workflow management systems and HistoCore specimen labeling solutions. Regulatory credentials include FDA clearances and IVD compliance. The division operates with over 3,000 global experts and emphasizes integrated solutions spanning tissue processing through digital pathology and computational diagnostics.